These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 18636247

  • 1. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.
    Qiu XY, Jiao Z, Zhang M, Zhong LJ, Liang HQ, Ma CL, Zhang L, Zhong MK.
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1069-84. PubMed ID: 18636247
    [Abstract] [Full Text] [Related]

  • 2. Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients.
    Qiu F, He XJ, Sun YX, Li-Ling J, Zhao LM.
    Pharmacol Rep; 2011 Nov; 63(3):815-25. PubMed ID: 21857093
    [Abstract] [Full Text] [Related]

  • 3. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation.
    Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G, Zhou HH.
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1093-8. PubMed ID: 17042920
    [Abstract] [Full Text] [Related]

  • 4. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
    Li DY, Teng RC, Zhu HJ, Fang Y.
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
    Bouamar R, Hesselink DA, van Schaik RH, Weimar W, Macphee IA, de Fijter JW, van Gelder T.
    Ther Drug Monit; 2011 Apr; 33(2):178-84. PubMed ID: 21383650
    [Abstract] [Full Text] [Related]

  • 6. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
    Zhang Y, Li JL, Fu Q, Wang XD, Liu LS, Wang CX, Xie W, Chen ZJ, Shu WY, Huang M.
    Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
    [Abstract] [Full Text] [Related]

  • 7. Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.
    Meng XG, Guo CX, Feng GQ, Zhao YC, Zhou BT, Han JL, Chen X, Shi Y, Shi HY, Yin JY, Peng XD, Pei Q, Zhang W, Wang G, He M, Liu M, Yang JK, Zhou HH.
    Acta Pharmacol Sin; 2012 Dec; 33(12):1563-70. PubMed ID: 23085740
    [Abstract] [Full Text] [Related]

  • 8. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis.
    Shi XJ, Geng F, Jiao Z, Cui XY, Qiu XY, Zhong MK.
    J Clin Pharm Ther; 2011 Oct; 36(5):614-24. PubMed ID: 21916909
    [Abstract] [Full Text] [Related]

  • 9. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y, Wang C, Li J, Wang X, Zhu G, Chen X, Bi H, Huang M.
    Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
    [Abstract] [Full Text] [Related]

  • 10. ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.
    García M, Macías RM, Cubero JJ, Benítez J, Caravaca F, Gervasini G.
    Eur J Clin Pharmacol; 2013 Mar; 69(3):385-93. PubMed ID: 22886152
    [Abstract] [Full Text] [Related]

  • 11. Association of CYP3A4*1B genotype with Cyclosporin A pharmacokinetics in renal transplant recipients: A meta-analysis.
    Wang CE, Lu KP, Chang Z, Guo ML, Qiao HL.
    Gene; 2018 Jul 20; 664():44-49. PubMed ID: 29678659
    [Abstract] [Full Text] [Related]

  • 12. Impact of CYP3A4*1B and CYP3A5*3 polymorphisms on the pharmacokinetics of cyclosporine and sirolimus in renal transplant recipients.
    Żochowska D, Wyzgał J, Pączek L.
    Ann Transplant; 2012 Jul 20; 17(3):36-44. PubMed ID: 23018254
    [Abstract] [Full Text] [Related]

  • 13. A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.
    Elens L, Bouamar R, Hesselink DA, Haufroid V, van der Heiden IP, van Gelder T, van Schaik RH.
    Clin Chem; 2011 Nov 20; 57(11):1574-83. PubMed ID: 21903774
    [Abstract] [Full Text] [Related]

  • 14. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
    Crettol S, Venetz JP, Fontana M, Aubert JD, Pascual M, Eap CB.
    Ther Drug Monit; 2008 Dec 20; 30(6):689-99. PubMed ID: 18978522
    [Abstract] [Full Text] [Related]

  • 15. Influence of the MDR1 haplotype and CYP3A5 genotypes on cyclosporine blood level in Chinese renal transplant recipients.
    Chen B, Zhang W, Fang J, Jin Z, Li J, Yu Z, Cai W.
    Xenobiotica; 2009 Dec 20; 39(12):931-8. PubMed ID: 19925383
    [Abstract] [Full Text] [Related]

  • 16. Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients.
    Cho JH, Yoon YD, Park JY, Song EJ, Choi JY, Yoon SH, Park SH, Kim YL, Kim CD.
    Transplant Proc; 2012 Jan 20; 44(1):109-14. PubMed ID: 22310591
    [Abstract] [Full Text] [Related]

  • 17. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE, Goodman LK, Tett SE.
    Clin Pharmacokinet; 2010 Mar 20; 49(3):141-75. PubMed ID: 20170205
    [Abstract] [Full Text] [Related]

  • 18. Frequencies and roles of CYP3A5, CYP3A4 and ABCB1 single nucleotide polymorphisms in Italian teenagers after kidney transplantation.
    Turolo S, Tirelli AS, Ferraresso M, Ghio L, Belingheri M, Groppali E, Torresani E, Edefonti A.
    Pharmacol Rep; 2010 Mar 20; 62(6):1159-69. PubMed ID: 21273673
    [Abstract] [Full Text] [Related]

  • 19. Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.
    Sharaki O, Zeid M, Moez P, Zakaria NH, Nassar E.
    Mol Biol Rep; 2015 Jan 20; 42(1):105-17. PubMed ID: 25240575
    [Abstract] [Full Text] [Related]

  • 20. CYP3A4 genetic polymorphisms predict cyclosporine-related clinical events in Chinese renal transplant recipients.
    Wang YY, Zhang M, Lu FM, Jiao Z, Qiu XY.
    Chin Med J (Engl); 2012 Dec 20; 125(23):4233-8. PubMed ID: 23217392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.